On September 15th, the Shenzhen Stock Exchange announced that the Listing Committee's 58th review meeting had been held, and Sanbo Brain Hospital Medical Management Group Co., Ltd. met the conditions for issuance, listing, and information disclosure.

Sanbo Brain Hospital is a portfolio company of CEC Capital.

On May 8th last year, Sanbo Brain Hospital announced raising over RMB 800 million in its Series B equity financing from Taikang Insurance Group, with participation from CEC Future Industrial Fund, GF XinDe Investment, Hongding Investment, PagodaTree Partners, BROADHI CAPITAL, Park Hill Capital, and other institutions. CEC Capital acted as the exclusive financial advisor in this transaction for Sanbo Brain Hospital.

Sanbo Brain Hospital is a renowned neurospecialty hospital group in China, established in 2004. Over 16 years of development, it has become a leading neurospecialty medical group in the country. The group operates seven large hospitals (including one under construction) in six provinces and cities, covering Beijing, Chongqing, Hunan, Fujian, Henan, and Yunnan. The flagship hospital, Sanbo Brain Hospital affiliated with Capital Medical University, is one of the top neurospecialty hospitals in China. In the medical service rankings released by the Beijing Municipal Commission of Health and Family Planning, it has consistently ranked among the top in neurosurgery, alongside Beijing Tiantan Hospital and Xuanwu Hospital.